Figure 1.

Growth chart of a typical patient with pediatric onset Crohn’s disease. Alterations in growth velocity were observed over the two years prior to the onset of disease symptoms (12 years) in this boy. Crohn’s disease was diagnosed at the age of 14 years, and he was treated with enteral nutrition and azathioprine, followed by infliximab. Use of corticosteroid was avoided to maximize his growth potential. The growth velocity was improved soon after commencing treatment, and achieved his target height at age of 18 years of age.